Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

51
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
51
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.3K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A high-molecular-weight polysaccharide from Polygonatum sibiricum inhibits distant tumor growth associated with gut microbiota remodeling and synergizes with αPD-1 therapy.

International journal of biological macromolecules·2026
Same author

Orientation-Entropy-Mediated Derivative Cu Sites for Selective CO<sub>2</sub> Electroreduction to Ethylene.

Angewandte Chemie (International ed. in English)·2026
Same author

Separated Energy Domains in the Sequential Hydration of a Benzonitrile Radical Cation.

Precision chemistry·2026
Same author

HOI-brain: A novel multi-channel transformers framework for brain disorder diagnosis by accurately extracting signed higher-order interactions from fMRI data.

Medical image analysis·2026
Same author

Power Defect Detection with Improved YOLOv12 and ROI Pseudo Point Cloud Visual Analytics.

Sensors (Basel, Switzerland)·2026
Same author

Classification of Alzheimer's Disease by Modeling Brain Networks as Signed Networks Under Deep Learning Frameworks.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
Same journal

Cross-subject fMRI-to-Image with Visual-cortex 2D Representation and Pre-Training.

IEEE journal of biomedical and health informatics·2026
Same journal

PGCASurv: A Prior-Guided Cross-Attention Framework for Dynamic Survival Model with Longitudinal Data.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Mar 14, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.8K

HyperSynergyX: Synergistic Drug Combination Prediction via Hypergraph Modeling and Knowledge Graph-Enhanced

Qi Wang, Bingzheng Wu, Minglang Xu

    IEEE Journal of Biomedical and Health Informatics
    |March 12, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Identifying synergistic three-drug combinations for complex diseases is difficult. HyperSynergyX, an explainable AI framework, predicts drug synergies and provides mechanistic explanations, accelerating multi-drug discovery for precision oncology.

    More Related Videos

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K

    Related Experiment Videos

    Last Updated: Mar 14, 2026

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.8K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.8K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K

    Area of Science:

    • Computational Biology
    • Pharmacology
    • Artificial Intelligence

    Background:

    • Drug combination therapy is crucial for complex diseases.
    • Predicting synergistic three-drug regimens is challenging due to combinatorial complexity and opaque models.

    Purpose of the Study:

    • Introduce HyperSynergyX, an explainable framework for predicting drug synergies and providing mechanistic explanations.
    • Accelerate multi-drug discovery and support rational regimen design in precision oncology.

    Main Methods:

    • Developed Dual-Biased Random Walk on Hypergraphs (DBRWH) to model higher-order drug interactions.
    • Integrated DBRWH with a knowledge-graph-enhanced retrieval augmented generation (KG-RAG) module for mechanistic interpretability.
    • Utilized tensor decomposition to identify latent combination patterns.

    Main Results:

    • DBRWH achieved AUROC/AUPRC of 0.9593/0.9453 on breast cancer data and 0.9262/0.9481 on lung cancer data.
    • Outperformed existing deep learning and hypergraph baselines in synergy prediction.
    • Generated biologically grounded hypotheses for predicted synergies.

    Conclusions:

    • HyperSynergyX offers a robust and transparent tool for multi-drug discovery.
    • The framework links predictive performance with mechanistic interpretability.
    • Facilitates rational drug regimen design in precision oncology.